Details for New Drug Application (NDA): 201686
✉ Email this page to a colleague
The generic ingredient in CLOPIDOGREL BISULFATE is clopidogrel bisulfate. There are fifty-four drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the clopidogrel bisulfate profile page.
Summary for 201686
Tradename: | CLOPIDOGREL BISULFATE |
Applicant: | Zydus Lifesciences |
Ingredient: | clopidogrel bisulfate |
Patents: | 0 |
Pharmacology for NDA: 201686
Mechanism of Action | Cytochrome P450 2C8 Inhibitors P2Y12 Receptor Antagonists |
Physiological Effect | Decreased Platelet Aggregation |
Suppliers and Packaging for NDA: 201686
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLOPIDOGREL BISULFATE | clopidogrel bisulfate | TABLET;ORAL | 201686 | ANDA | Zydus Lifesciences Limited | 70771-1062 | 70771-1062-0 | 1000 TABLET, FILM COATED in 1 BOTTLE (70771-1062-0) |
CLOPIDOGREL BISULFATE | clopidogrel bisulfate | TABLET;ORAL | 201686 | ANDA | Zydus Lifesciences Limited | 70771-1062 | 70771-1062-3 | 30 TABLET, FILM COATED in 1 BOTTLE (70771-1062-3) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 75MG BASE | ||||
Approval Date: | Oct 10, 2012 | TE: | RLD: | No |
Complete Access Available with Subscription